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Abstract
Purpose After surgical treatment of high-grade soft tissue sar-
comas, local recurrences, metastases and survival remain a
great concern. Further knowledge on factors with a possible
impact on these endpoints, specifically resection margins, is
relevant for decision-making regarding the aggressiveness of
local treatment. The aim of this study is to investigate the
impact of prognostic factors on local recurrence and overall
survival for patients with high-grade soft tissue sarcomas of
the extremities.
Methods In a retrospective cohort study of 127 patients (mean
age 48 years, range five to 91; median follow-up 71 months)
the prognostic effect of margin status and other clinicopatho-
logic characteristics on local recurrence and overall survival
were analysed by employing a multivariate Cox regression.
Results Five-year cumulative incidence of local recurrence
and distant metastases was 26 % and 40 %, respectively.
The estimated five-year overall survival was 59 %. Tumour
size proved a consistent adverse prognostic factor for local
recurrence (hazard ratio (HR) 3.9), distant metastasis (HR
4.9) and overall survival (HR 2.4). The significant association
of resection margins with local recurrence (HR 10.2) was
confirmed.Margins were however not significantly associated
with the occurrence of distant metastasis or overall survival.
The occurrence of local recurrence had a significant impact on
overall survival (HR 2.0).
Conclusions The results of this study confirm the critical role
of tumour size on survival and margins on local recurrence,
and stress the need for further investigation concerning the
association between margins, local recurrence and survival.
Keywords Soft tissue sarcoma . Treatment .Margins .
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Introduction
Soft tissue sarcomas (STS) are a rare (incidence 1:30.000)
heterogeneous group of tumours accounting for approximate-
ly 1 % of all adult cancers [1]. Despite continuous improve-
ments in imaging, surgical techniques and adjuvant treatment,
local recurrences, distant metastasis and death remain of great
concern especially in high-grade tumours. Five-year cumula-
tive incidence rates range from 12 to 28% for local recurrence
and 21–40 % for distant metastasis [2–6]. Defining a consis-
tent set of prognostic variables for these oncologic end-points
has proven challenging due to the heterogeneity and low in-
cidence of high-grade tumours (≈38 % of all STS) [7]. Some
factors have consistently proven to be predictive of adverse
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events, such as histotype, depth, histological grade, and size
[2–11]. The role of resection margins has also been extensive-
ly studied in highly heterogeneous sarcoma populations.
There is general agreement that positive margins are associat-
ed with a higher risk of local recurrence [4–6, 8–11]. The
association between resection margins and distant metastasis
or overall survival however remains unclear [3, 4, 6, 8–11].
The majority of studies addressing this issue have included all
histologic grades and sarcoma types leading to general out-
comes, which are intricate to use in a clinical setting.
Questioning the effect of margins and local recurrences on
survival remains relevant, as it influences the extent of local
and adjuvant treatment. This study focuses only on STS of
high grade to improve understanding of this subgroup of
unfavourable STS that is more homogeneous in the context
of survival outcomes.
A competing risks model was used to estimate the cumu-
lative incidence of local recurrence and distant metastasis.
When the situation is such that the occurrence of an event
(e.g., death) prevents the event of interest (e.g., local recur-
rence) from happening, a competing risks model must be ap-
plied [12]. If this analysis is not used, the cumulative inci-
dence rate (the probability of failure from a specific cause) is
generally overestimated.
The objective of this study was to evaluate the effect of
margins, adjusted for other known risk factors, on local recur-
rence, distant metastases, and overall survival.
Patients and methods
A retrospective analysis of patients surgically treated between
2000 and 2007 at our two tertiary referral centres for primary,
high-grade, STS of the extremities (ESTS) was performed.
From the pathology databases 161 patients with one of four
most common high-grade ESTS diagnoses—high-grade
myxofibrosarcoma, synovial sarcoma, malignant peripheral
nerve sheath tumour, or angiosarcoma—were identified. Ex-
clusion criteria were metastatic disease at time of diagnosis,
presentation with recurrent disease, no operative treatment
with curative intent at our institutions, and an unknown mar-
gin status. All patients had pre-treatment staging with a lung
CT-scan to rule out the presence of metastasis. Thirty-four
patients were excluded from analysis (presentation with me-
tastases (11), recurrent disease (16), no operative treatment
(7)) resulting in a cohort of 127 patients (mean age at time
of diagnosis: 48 years (range five to 91), including nine chil-
dren; male/female ratio 1:0.87).
Medical records including operative and pathologic reports
were reviewed and the following information was recorded:
age, gender, presentation status (no treatment/biopsy only vs.
prior (Whoops) excision), tumour size (small (<50 mm) vs.
intermediate (50–100 mm) vs. large (≥100 mm)[8]), depth
(superficial vs. deep to investing fascia), location (upper vs.
lower extremity), involvement of adjacent structures, surgical
margin, adjuvant therapy (radiotherapy vs. no radiotherapy;
chemotherapy vs. no chemotherapy), and follow-up data. Ta-
ble 1 summarizes patient , tumour and treatment
characteristics.
Independent experienced musculoskeletal pathologists
(PH, JB, AF) defined the closest surgical margin after inking
and sectioning of the specimen. The closest identified resec-
tion margin was categorized as follows: intralesional for a
positive margin with tumour cells visible at the inked margin
(12 %), marginal for a margin of 2 mm or less (58 %), or wide
for a negative margin of more than 2 mm (30 %) [13]. The
decision concerning the use of adjuvant treatment was not
uniform during the study period due to progressing insights
in the lapse of time, although nearly all patients (80 %) re-
ceived radiotherapy. The most common regimen was 50Gy on
the target region and a boost of 10Gy on the tumour region.
Adjuvant therapy was omitted in 24 (19 %) patients for vari-
ous reasons (amputation, patient preference (seven patients),
superficial tumours (seven tumours) or wide resectionmargins
(12 patients)). No other adjuvant therapies, besides chemo-
therapy or radiotherapy, were administered.
Local recurrence was defined as the first clinical, radiolog-
ical or pathological manifestation of tumour of the same his-
tologic type within or contiguous to the previously treated
tumour bed, one or more months after primary treatment. Dis-
tant recurrence was defined by clinical or radiological evident
systemic spread of tumour outside the primary tumour bed,
including nodal metastasis. Dates of death were extracted
from the medical records, which were coupled to the general
registry of the hospital.
Statistical analysis
The outcomes of interest were five year cumulative incidence
of local recurrence and distant metastasis, and five year overall
survival rate. Synchronous local and distant recurrences were
considered as separate events in the analysis of local recur-
rence and distant metastasis. Time to recurrence and time to
death were estimated from date of first surgery (excluding
previous Whoops excisions). Survival end-point was date of
last follow-up or death. The median follow-up, as assessed by
employing the reverse Kaplan-Meier method [14], was
71 months (95 % CI 62–80).
The following variables were tested for univariate associa-
tion with local-recurrence, distant-recurrence and survival
using the log rank test statistic: age, gender, anatomic site,
tumour growth, depth, previous Whoops excision, planned
primary amputation, margin, histological subtype, and adju-
vant radio- or chemotherapy. Factors identified as significant
were included in the multivariate analysis. For local recur-
rence and distant metastasis a cause-specific multivariate
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hazard Cox regression model was applied. The cause-specific
hazard function is the fundamental concept in the competing
risks model; it provides the hazard of failing from a specific
cause in the presence of the competing events [12]. For overall
survival a Cox model with local and distant recurrences as
time-dependent covariates was estimated.P values at or below
0.05 were considered significant. To check the proportional
hazards assumption we looked at the Shoenfeld residuals. Sta-
tistical analyses were performed in SPSS (version 20; IBM
Corp, Armonk, NY) and R 2–18 [15]. All analyses concerning
competing risks were performed with the MState library [16].
Results
Disease outcome and patient survival
Five year cumulative incidence of local recurrence and distant
metastases was 26 % and 40 %, respectively. The estimated
five-year overall survival was 59 % with a median survival
time of 79 months (95 % CI, 65–93 months) (Fig. 1).
Among patients with intralesional margins, six (50 %) and
seven (58 %) patients developed a local recurrence and/or
distant metastasis, respectively. This was the case for 22
(30 %) and 32 (43 %) patients with marginal margins, and
three (8 %) and 11 (29 %) patients with wide margins. Even-
tually, seven (47 %), 37 (50 %), and 14 (47 %) patients with
intralesional, marginal, or wide margins, respectively, died.
Prognostic factors
Table 2 shows the results from the univariate and multivariate
analyses for all endpoints.
Univariate prognostic factors for local recurrence were
margin status, tumour size, and age. For distant metastases,
tumour size and a presentation after ‘Whoops’ surgery were
significant factors. Tumour size, age and a primary limb spar-
ing operation (vs. amputation) were significant factors for
overall survival. Radiotherapy did not emerge as a significant
univariate prognostic factor for either endpoint; merely a
slight trend towards better survival was observed.
In the multivariate analysis, prognostic factors for local
recurrence were margins and tumour size. Patients with
intralesional and marginal resection margins had 10.2 times
(95 % CI, 2.5–42.4) and 4.8 times (95 % CI, 1.4–16.2) higher
risk (95 % CI, 1.4–16.2) of experiencing local recurrence,
respectively. Patients presenting with large tumours
(≥100 mm) had 3.9 times higher risk (95 % CI, 1.5–10.4) of
developing a local recurrence compared to patients with small
(<50 mm) tumours. In Figs. 2 and 3 the cumulative incidence
curves of local recurrence are represented for resection margin
and tumour size respectively. For distant metastases, tumour
size remained the only prognostic factor associated with the
occurrence of distant metastases (hazard ratio 4.9 (95 % CI,
1.9–12.4) and 2.4 (95 % CI, 0.9–6.2)) for large and interme-
diate tumours, respectively). No correlation between tumour
Table 1 Patient, tumour and treatment characteristics of high-grade
soft tissue sarcomas of the extremities





No treatment/biopsy only 102 80.3
Prior excision 25 19.7
Tumour location
Upper extremity 25 19.7
Lower extremity 102 80.3
Tumour size
<50 mm 36 28.3
50–99.9 mm 44 34.6










Synovial sarcoma 45 35.4
Sarcoma nos 4 3.1
Surgical margin
Intralesional 15 11.8
Marginal 0-2 mm 74 58.3














MPNSTmalignant peripheral nerve sheath tumour, Sarcoma nos sarcoma
not otherwise specified
a Depth: relative to the investing fascia
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size and surgical margins could be observed (Table 3). To
assess the impact of risk factors on overall survival a Cox
model with local recurrence as time-dependent variable has
been estimated. Independent significant factors were size and
presence of local recurrence. The hazard ratio for tumour size
was equal to 2.4 (95%CI, 1.1–2.9) and 1.1 (95%CI, 0.5–2.5)
for patients with large or intermediate tumours, respectively,
compared to patients with small tumours. Development of a
local recurrence was associated with a 2.0-fold (95 % CI, 1.1–
3.7) increased risk of death. A Cox model with distant metas-
tasis as time-dependent covariate was also employed. As ex-
pected the hazard ratio associated with distant metastasis was
extremely high, outweighing all other prognostic variables. As
a result none showed a significant statistical effect. The risk of
death increased 17-fold with a distant metastasis (95 % CI,
8.6–33.3).
Discussion
Surgery remains the cornerstone of treatment for patients with
ESTS. Although local control is one of the primary objectives
of treatment, the question is whether this has to be sought for
at every extent, leading to possibly unacceptable functional
outcomes. The lack of unambiguous evidence that margins
and local control influence survival further complicates deci-
sion-making. Moreover, results from many studies are
confounded by the amount of histological subtypes included.
Therefore this study aimed to define the influence of the extent
of local treatment (i.e., margins) in the light of other prognos-
tic factors on local recurrence and survival in a specific group
of high-grade ESTS.
The cumulative incidences of local recurrence and distant
metastases at five years were 26 % and 40 %, respectively.
Five-year overall survival was 59 %. These results are some-
what less optimistic than those previously published, although
a comparison is difficult due to differences in the patient pop-
ulation (high grade vs. all STS subtypes) and statistical
methods [2, 17, 18]. As expected, tumour size was a consistent
adverse prognostic risk factor for the occurrence of local re-
currence, distant metastasis, and overall survival, in agreement
with published results [4, 6, 11, 19].
In this series, intralesional and marginal margins had a
significant effect on the development of local recurrences,
while the development of distant metastases and overall sur-
vival were not significantly affected by the surgical margin.
This apparent controversial manifestation has been reported
previously, although a clear explanation is still lacking. Gen-
erally it is hypothesized that these results can be explained on
the basis of tumour-specific or biologic factors, with highly
aggressive tumours leading to greater risk of distant spread
and subsequent death irrespective of local surgery [4, 8, 9,
17, 20]. Following from this, the question of the prognostic
role of local recurrence arises. In this study, the occurrence of
Fig. 1 Overall survival
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local recurrence was associated with an increased risk of
death, as shown in several studies [2, 13, 10, 19], while others
show no association between local recurrence and overall sur-
vival [9, 21, 22]. As to the cause of the increased risk we can
merely hypothesize between a direct effect of local recurrence
on survival and an indirect effect with local recurrence as a
marker of high biological tumour aggressiveness. The latter
would implicate that the described relationship between local
recurrences and overall survival is a result of selection bias.
The outcomes of this study reflect the unresolved discussion,
with local recurrence as an adverse prognostic factor for sur-
vival on one hand, while the lack of a relationship between
surgical margins and overall survival argues for local recur-
rence as a marker of tumour aggressiveness.
When evaluating the effect of margin status, the inconsis-
tencies in definitions of positive margins are an obvious prob-
lem. Most investigations classify margin as positive (R1) or
negative (R0) margins, because application of Enneking
criteria is hampered in retrospective studies. A solely positive
or negative status of a margin however, gives no insight into
the difference between clear but close margins and wider mar-
gins. Exactly this distinction is important in the light of spar-
ing as much tissue as possible for preferable functional out-
comes [23]. With improvements in preoperative planning
using MRI and the use of (neo) adjuvant therapy, sufficient
margins have gotten evermore narrow and the classification of
a wide margin as >2 mm is more in line with the reality of
current deep, high-grade STS resections [6].
Due to the presence of a competing risk (death) precluding
an event of interest (local recurrence, metastasis), this study
applies the competing risk model. In the presence of compet-
ing risks, the Kaplan–Meier method generally overestimates
the risk of the event at interest, because it assumes that patients
who experienced the competing event are still at risk for the
event of interest and thus cumulative probabilities are
overestimated [24]. We feel it needs to be noted that many
studies, upon which clinical decisions are made, simply over-
look the competing risk situation.
Some limitations are present in our study. First of all, due
to the low incidence of these sarcomas our sample size is
small. This might account for the fact that some expected
prognostic factors, such as age or limb sparing procedure,
were not significant in our analysis. The second aspect con-
cerns the retrospective nature of the study where selection
bias and confounding cannot be excluded. Due to the
multicentre aspect of the study the pathologic specimens
were neither evaluated by the same pathologist nor were
they reviewed to ensure consistency in reporting. Finally,
the lack of standardization of adjuvant therapy is a limita-
tion. It has been well established that adjuvant radiotherapy
improves local control of STS. The impact on overall sur-
vival has however not been established [25]. An attempt to
further analyse this aspect was not made in this study. How-
ever, there were no significant differences in outcome by
any of the adjuvant treatment parameters, except a slight
trend of better survival for those receiving adjuvant radio-
therapy. In this study 80 % of the patients received adjuvant
treatment, thus this minor trend may likely be based on
selection bias.
This study shows that tumour size is a consistent adverse
prognostic factor for local recurrence, distant metastasis, and
overall survival. In addition, our data show a correlation be-
tween resection margins and the occurrence of local recur-
rence. This correlation was not observed for the occurrence
of distant metastases or overall survival, while simulta-
neously a trend of an increased risk of death after local
recurrence was noted. The results of this study emphasize
once more the need for further convincing evidence of the
influence of margins and local recurrence on survival in
high-grade ESTS, while stressing the importance of early
diagnosis and treatment, with tumour size as the most im-
portant prognostic factor.
Fig. 2 Cumulative incidence of local recurrence for margins
Fig. 3 Cumulative incidence of local recurrence for tumour size
Table 3 Overview of resection margins by tumour size
Tumour size Number, n Intralesional Marginal Wide
Small (<50 mm) 36 4 (11 %) 22 (61 %) 10 (28 %)
Intermediate 44 6 (14 %) 23 (52 %) 15 (34 %)
Large (>100 mm) 42 5 (12 %) 25 (60 %) 12 (29 %)
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